Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Merck & Company Inc

MRK
Current price
85.67 USD -0.4 USD (-0.46%)
Last closed 89.67 USD
ISIN US58933Y1055
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 248 031 199 232 USD
Yield for 12 month -31.91 %
1Y
3Y
5Y
10Y
15Y
MRK
21.11.2021 - 28.11.2021

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. vIt has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. It also has licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey. Address: 126 East Lincoln Avenue, Rahway, NJ, United States, 07065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

128.73 USD

P/E ratio

20.51

Dividend Yield

3.78 %

Current Year

+60 115 000 000 USD

Last Year

+59 283 000 000 USD

Current Quarter

+16 657 000 000 USD

Last Quarter

+16 156 000 000 USD

Current Year

+43 989 000 000 USD

Last Year

+41 872 000 000 USD

Current Quarter

+12 577 000 000 USD

Last Quarter

+11 863 000 000 USD

Key Figures MRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 22 927 998 976 USD
Operating Margin TTM 26.20 %
PE Ratio 20.51
Return On Assets TTM 10.53 %
PEG Ratio 0.068
Return On Equity TTM 28.33 %
Wall Street Target Price 128.73 USD
Revenue TTM 63 174 000 640 USD
Book Value 17.58 USD
Revenue Per Share TTM
Dividend Share 3.04 USD
Quarterly Revenue Growth YOY 4.40 %
Dividend Yield 3.78 %
Gross Profit TTM 42 077 000 000 USD
Earnings per share 4.78 USD
Diluted Eps TTM 4.78 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -33.30 %
Profit Margin 19.23 %

Dividend Analytics MRK

Champion - 10+ consecutive years of dividend increases

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

6.84 %

5Y Dividend Growth

45.00 %

Consecutive Years

14 years

5Y Average Payout Ratio

104.00 %

Dividend History MRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3.24
Ex Dividend Date 16.12.2024
Forward Annual Dividend Yield 3.30 %
Last Split Factor 1048:1000
Payout Ratio 52.44 %
Last Split Date 03.06.2021
Dividend Date 08.01.2025
Consecutive Years 14
Consistent Years 20
Continuous Dividends 55

Stock Valuation MRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 20.51
Forward PE 10.12
Enterprise Value Revenue 4.30
Price Sales TTM 3.93
Enterprise Value EBITDA 14.12
Price Book MRQ 5.57

Financials MRK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MRK

For 52 weeks

93.73 USD 132.67 USD
50 Day MA 102.37 USD
Shares Short Prior Month 26 228 480
200 Day MA 117.92 USD
Short Ratio 2.70
Shares Short 32 788 187
Short Percent 1.30 %